Syngene Internation.

₹580.5 3 | 0.5%

WEBSITE BSE:539268 NSE : SYNGENE 23 Mar, 16:01

Market Cap ₹23382 Cr.

Stock P/E 53.7

P/B 6.9

Current Price ₹580.5

Book Value ₹ 84.3

Face Value 10

52W High ₹683

Dividend Yield 0.17%

52W Low ₹ 511.5

Edit Ratio

Syngene Internation. Research see more...

Syngene International Ltd

Overview Inc. Year: 1993Industry: Miscellaneous

Syngene International Ltd is a contract research enterprise. The Company is engaged in providing agreement research and manufacturing services in early-stage drug discovery and development to pharmaceutical and biotechnology companies. Its offerings consist of discovery chemistry and biology offerings, toxicology, pharmaceutical development, technique improvement/manufacture of intermediates, active pharmaceutical ingredients and bio-therapeutics. Its services consists of integrated, discovery and development offerings for novel molecular entities (NMEs) across commercial sectors, such as pharmaceutical, biopharmaceutical and biotechnology, amongst others. It specializes in undertaking discovery (from hit to candidate selection), development (together with pre-scientific and clinical studies, analytical and bio-analytical evaluation, and stability studies) and manufacturing (scale-up, pre-clinical and manufacturing components). It serves customers ranging from multinational agencies to start-ups.

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Syngene Internation. Quarterly Results

#(Fig in Cr.)	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022
Net Sales	520	585	659	595	610	641	758	645	768	786
Other Income	21	26	23	28	23	33	24	16	15	17
Total Income	540	611	682	622	634	674	782	660	784	803
Total Expenditure	371	417	448	445	443	458	517	472	552	555
Operating Profit	170	193	234	177	190	216	265	188	232	248
Interest	7	7	7	8	1	9	6	9	12	14
Depreciation	69	70	70	75	76	79	80	86	90	95
Exceptional Income / Expenses	0	0	35	0	-31	0	0	0	0	0
Profit Before Tax	94	117	192	95	82	128	179	93	130	140
Provision for Tax	10	14	32	17	16	24	31	19	28	30
Profit After Tax	84	102	161	77	67	104	148	74	102	110
Adjustments	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	84	102	161	77	67	104	148	74	102	110
Adjusted Earnings Per Share	2.1	2.6	4	1.9	1.7	2.6	3.7	1.8	2.5	2.7

Syngene Internation. Profit & Loss

#(Fig in Cr.)	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	TTM
Net Sales	1423	1826	2012	2184	2604	2957
Other Income	136	76	96	83	108	72
Total Income	1559	1902	2108	2268	2713	3029
Total Expenditure	1033	1290	1409	1531	1864	2096
Operating Profit	527	612	700	736	849	933
Interest	23	32	35	28	24	41
Depreciation	131	164	219	275	310	351
Exceptional Income / Expenses	0	0	71	35	-31	0
Profit Before Tax	373	415	517	469	484	542
Provision for Tax	67	84	105	64	89	108
Profit After Tax	305	332	412	405	396	434
Adjustments	0	0	0	0	0	0
Profit After Adjustments	305	332	412	405	396	434
Adjusted Earnings Per Share	7.6	8.3	10.3	10.1	9.9	10.7

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	19%	13%	0%	0%
Operating Profit CAGR	15%	12%	0%	0%
PAT CAGR	-2%	6%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	-4%	38%	15%	NA%
ROE Average	13%	17%	17%	17%
ROCE Average	13%	16%	16%	16%

Syngene Internation. Balance Sheet

#(Fig in Cr.)	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Shareholder's Funds	1720	1968	2176	2821	3298
Minority's Interest	0	0	0	0	0
Borrowings	586	347	0	512	532
Other Non-Current Liabilities	27	168	325	327	440
Total Current Liabilities	784	1129	1539	1133	1229
Total Liabilities	3117	3612	4040	4794	5498
Fixed Assets	1030	1337	1984	2163	2354
Other Non-Current Assets	366	511	444	824	938
Total Current Assets	1720	1764	1613	1807	2206
Total Assets	3117	3612	4040	4794	5498

Syngene Internation. Cash Flow

#(Fig in Cr.)	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Opening Cash & Cash Equivalents	235	253	165	193	323
Cash Flow from Operating Activities	446	630	677	701	581
Cash Flow from Investing Activities	-349	-647	-428	-628	-612
Cash Flow from Financing Activities	-79	-72	-226	58	-31
Net Cash Inflow / Outflow	18	-89	23	131	-62
Closing Cash & Cash Equivalent	253	165	193	323	262

Syngene Internation. Ratios

#	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Earnings Per Share (Rs)	7.64	8.29	10.3	10.12	9.88
CEPS(Rs)	10.92	12.4	15.79	16.99	17.6
DPS(Rs)	1	0.5	0	0	1
Book NAV/Share(Rs)	42.31	48.51	53.42	68.61	80.09
Core EBITDA Margin(%)	27.44	29.34	29.99	29.9	28.43
EBIT Margin(%)	27.77	24.52	27.41	22.75	19.53
Pre Tax Margin(%)	26.18	22.75	25.69	21.48	18.6
PAT Margin (%)	21.46	18.16	20.48	18.54	15.2
Cash Profit Margin (%)	30.69	27.16	31.38	31.1	27.09
ROA(%)	9.8	9.86	10.77	9.17	7.69
ROE(%)	18.05	18.26	20.21	16.59	13.29
ROCE(%)	15.76	16.98	19.6	15.4	13.24
Receivable days	68.43	60.53	66.84	73.02	68.92
Inventory Days	22.06	12.94	6.22	7.09	16.75
Payable days	194.6	146.67	156.53	160.7	115.59
PER(x)	38.56	35.46	23.45	53.68	60.44
Price/Book(x)	6.96	6.06	4.52	7.92	7.45
Dividend Yield(%)	0.17	0.09	0	0	0.17
EV/Net Sales(x)	8.15	6.64	5	10.01	9.29
EV/Core EBITDA(x)	22.02	19.81	14.39	29.69	28.5
Net Sales Growth(%)	0	28.28	10.2	8.57	19.22
EBIT Growth(%)	0	13.28	23.19	-9.9	2.33
PAT Growth(%)	0	8.58	24.28	-1.75	-2.25
EPS Growth(%)	0	8.58	24.28	-1.75	-2.44
Debt/Equity(x)	0.47	0.41	0.32	0.28	0.25
Current Ratio(x)	2.2	1.56	1.05	1.59	1.8
Quick Ratio(x)	2.13	1.54	1.03	1.55	1.65
Interest Cover(x)	17.41	13.86	15.94	17.94	21.1
Total Debt/Mcap(x)	0.07	0.07	0.07	0.04	0.03

Syngene Internation. Shareholding Pattern

#	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022
Promoter	70.61	70.59	70.58	70.43	70.42	70.41	70.41	70.29	64.86	64.86
FII	14.58	14.29	14.25	14.4	14.07	13.82	13.67	14.12	16.77	16.85
DII	6.68	5.81	5.27	4.77	4.82	4.43	4.43	4.21	6.77	7.04
Public	8.13	9.31	9.9	10.4	10.68	11.33	11.49	11.38	11.6	11.25
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022
Promoter	28.24	28.23	28.23	28.23	28.22	28.22	28.22	28.22	26.04	26.04
FII	5.83	5.72	5.7	5.77	5.64	5.54	5.48	5.67	6.73	6.76
DII	2.67	2.33	2.11	1.91	1.93	1.78	1.78	1.69	2.72	2.83
Public	3.25	3.72	3.96	4.17	4.28	4.54	4.6	4.57	4.65	4.52
Others	0	0	0	0	0	0	0	0	0	0
Total	40	40	40	40.08	40.08	40.08	40.08	40.14	40.14	40.14